89601-09-2

Usage

Uses

Used in Pharmaceutical Manufacturing:
2,3-Piperazinedicarboxylic acid (6CI, 7CI, 9CI) is used as a building block for the synthesis of various drugs. Its chemical structure allows for the creation of a wide range of pharmaceutical compounds, making it an essential component in the development of new medications.
Used in Agrochemical Production:
PDCA is used in the manufacturing of agrochemicals, contributing to the development of effective products for agricultural applications. Its versatility in chemical synthesis enables the production of compounds that can be used in pest control and crop protection.
Used in Chelating Agent Production:
2,3-Piperazinedicarboxylic acid (6CI, 7CI, 9CI) is used as a key component in the production of chelating agents. These agents are essential in various industrial processes, including water treatment and metal extraction, due to their ability to bind and stabilize metal ions.
Used as a Corrosion Inhibitor:
PDCA is employed as a corrosion inhibitor, protecting materials from the damaging effects of corrosion. Its application in this field is particularly valuable in industries that rely on metal components, such as automotive, aerospace, and construction.
Used in Antioxidant Applications:
2,3-Piperazinedicarboxylic acid (6CI, 7CI, 9CI) is used for its antioxidant properties, which can help protect against oxidative stress and damage in various applications. This makes it a potential candidate for use in health supplements and other products aimed at promoting overall well-being.
Used in Disease Treatment Research:
PDCA has potential applications in the treatment of certain diseases and conditions, making it a valuable compound in the field of medicinal chemistry. Its use in this area is currently under investigation, with the aim of developing new therapeutic strategies and treatments.

InChI:InChI=1/C6H10N2O4/c9-5(10)3-4(6(11)12)8-2-1-7-3/h3-4,7-8H,1-2H2,(H,9,10)(H,11,12)

Upstream product

• 89-01-0 2,3-dicarboxypyrazine 

Downstream Products

• 684283-16-7 (2RS,3RS)-1-(phenanthren-2-ylcarbonyl)piperazine-2,3-dicarboxylic acid 
• 94856-92-5 BBP 
• 858131-66-5 (+/-)-cis-PPDA 

Relevant academic research and scientific papers

Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists

The binding site for competitive NMDA receptor antagonists is on the NR2 subunit, of which there are four types (NR2A-D). Typical antagonists such as (R)-AP5 have a subunit selectivity of NR2A > NR2B > NR2C > NR2D. The competitive NMDA receptor antagonist

Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents

Disclosed are compounds of formula (I) wherein: L is (a) optionally substituted by replacement of one or more of the hydrogen atoms on the phenanthrene ring system by one or more groups other than hydrogen; A is CH2, SO2 or C=O; X is CO2H, PO3H2, PO2H2, PO2HR5, PO2HOR5, SO3H, SO2H, or tetrazole; and R1, R2, R3, R4 and R5 are independently selected from H, alkyl, alkenyl, alkynyl, aryl and aralkyl; or a pharmaceutically acceptable acid salt or base addition salt or an in vivo hydrolysable ester or amide thereof. Compounds of formula (I) are selective NMDA receptor modulating agents and, therefore, may be used to advantage in vitro in neuroassays and in vivo in the treatment of disorders of the CNS.

Diamide compound and drugs containing the same

The present invention provides diamide derivatives represented by the following general formula (1): wherein A is a phenyl group or the like, which may be substituted, B is —CH═CH—, —C═C—, —(CH═CH)2—, —C≡C—CH═CH—, —CH═CH—C≡C—, phenylene or the

Hydroformylation of olefins using azoxy-dentated ligands

At a temperature in the range 100° C to 225° C the destructive dissociation of cobalt carbonyl compounds to cobalt metal and residue is inhibited by the action of one or more azoxy-dentated chelation ligands.